StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
43
This month
2
This year
7
Publishing Date
2024 - 04 - 16
1
2024 - 04 - 01
1
2024 - 03 - 27
1
2024 - 02 - 28
1
2024 - 02 - 01
1
2024 - 01 - 25
1
2024 - 01 - 12
1
2023 - 10 - 03
1
2023 - 08 - 16
1
2023 - 06 - 16
1
2023 - 04 - 17
1
2023 - 04 - 07
1
2023 - 03 - 27
1
2023 - 03 - 20
1
2023 - 02 - 24
1
2023 - 02 - 22
1
2023 - 02 - 20
1
2022 - 11 - 01
1
2022 - 10 - 19
2
2022 - 10 - 14
2
2022 - 10 - 04
1
2022 - 09 - 22
1
2022 - 09 - 13
1
2022 - 09 - 09
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 08 - 03
1
2022 - 07 - 21
1
2022 - 05 - 26
1
2022 - 05 - 18
1
2022 - 05 - 17
1
2022 - 04 - 25
1
2022 - 04 - 07
1
2022 - 03 - 23
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 28
2
2022 - 02 - 01
1
2021 - 12 - 16
1
2021 - 11 - 12
1
Sector
Communications
1
Health services
1
Health technology
43
Manufacturing
6
Mining, quarrying, and oil and gas extraction
1
N/a
3
Process industries
2
Producer manufacturing
2
Professional, scientific, and technical services
1
Technology services
2
Tags
Acquire
1
Acute myeloid leukemia
1
Advanced
1
Als
1
Alzheimer's
1
America
3
Aml
1
Antibody
1
Asia
1
Bat2306
1
Bat2606
1
Benefits
1
Bio-nc
1
Biosimilar
2
Breast cancer
1
Business
1
Cancer
5
Cancer drug
1
Cel
1
Clinical trials
1
Cosentyx
1
Dementia
1
Dermatitis
1
Dermatological
1
Diabetes
1
Diagnostic
1
Diagnostics
3
Disease
3
Drug
4
Events
1
Expected
1
Eye
1
Financial
2
Global
11
Growing
3
Growth
11
Hepatitis
1
Hormone
1
Key
2
Kidney
1
Leaders
1
Leukemia
1
Market
26
Melanoma
1
Money
1
Myeloid leukemia
1
N/a
38
Novartis
2
Nucala
1
Ocular
1
Ongoing
1
Phase 1
1
Precision
1
Report
9
Research
6
Solutions
2
Therapeutics
4
Therapy
2
Treatment
2
Trial
2
Entities
3m company
1
Abbott laboratories
4
Abbvie inc.
12
Acelyrin, inc.
1
Adaptimmune therapeutics plc
1
Advaxis, inc.
1
Agenus inc.
1
Albemarle corporation
2
Alcon inc.
1
Amgen inc.
3
Aravive, inc.
1
Astellas pharma inc
4
Astrazeneca plc
9
Bausch health companies inc.
2
Baxter international inc.
2
Biofrontera ag
1
Biogen inc.
1
Boston scientific corporation
1
Brainstorm cell therapeutics inc.
1
Bristol-myers squibb company
4
Caribou biosciences inc
1
Catalent, inc.
1
Cel-sci corporation
1
Celyad oncology sa
1
Cerner corporation
1
Coherus biosciences, inc.
1
Curis, inc.
1
Cytrx corp
1
Eli lilly and company
9
Endo international plc
1
Erasca inc
1
Evelo biosciences, inc.
1
Galapagos nv
1
Gilead sciences, inc.
1
Glaxosmithkline plc
13
Hillenbrand inc
1
Humanigen, inc.
1
Icad inc.
1
Icon plc
1
Incyte corporation
2
Insulet corporation
1
Iveric bio, inc.
1
Johnson & johnson
10
Karyopharm therapeutics inc.
1
Kura oncology, inc.
1
Lonza group ag
1
Macrogenics, inc.
1
Mallinckrodt plc
1
Meridian bioscience inc.
1
Mesoblast ltd
1
Morphosys ag
1
Novartis ag
43
Novo nordisk a/s
2
Ocular therapeutix, inc.
1
Pfizer, inc.
2
Sanofi
9
Takeda pharmaceutical company limited
5
Teva pharmaceutical industries ltd
5
Thermo fisher scientific inc
3
Viatris inc.
2
Symbols
AAPL
40
ABB
68
ABBV
42
ABLZF
60
ABT
60
AFMD
41
ARVL
160
BDX
68
BNTX
57
CSCO
41
CSIQ
59
DOW
43
DSGX
50
EGAN
40
ERIC
52
EXK
47
FNCTF
308
GE
47
GIB
43
GLAXF
44
GSK
55
HITI
55
HON
104
HUBS
329
IBM
58
IGT
48
IMUX
49
INFY
44
JNJ
200
KALV
51
LLY
111
LTUM
71
MDT
44
MMM
41
MRK
43
MS
220
MSFT
52
MT
41
NOC
43
NVS
52
NVSEF
43
PFE
66
PPRUF
53
PPRUY
53
PSN
46
QTRHF
41
SAP
66
SAPGF
55
SNY
269
SNYNF
218
SRE
65
STN
44
TECH
41
TFX
78
TLRY
52
TMO
84
TNXP
51
TRMB
78
TRU
58
VIAV
60
Exchanges
Amex
1
Nasdaq
43
Nyse
43
Crawled Date
2024 - 04 - 16
1
2024 - 04 - 01
1
2024 - 03 - 27
1
2024 - 02 - 28
1
2024 - 02 - 01
1
2024 - 01 - 25
1
2024 - 01 - 12
1
2023 - 10 - 03
1
2023 - 08 - 16
1
2023 - 06 - 16
1
2023 - 04 - 17
1
2023 - 04 - 07
1
2023 - 03 - 27
1
2023 - 03 - 20
1
2023 - 02 - 24
1
2023 - 02 - 22
1
2023 - 02 - 20
1
2022 - 11 - 01
1
2022 - 10 - 19
2
2022 - 10 - 14
2
2022 - 10 - 04
1
2022 - 09 - 22
1
2022 - 09 - 13
1
2022 - 09 - 09
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 08 - 03
1
2022 - 07 - 21
1
2022 - 05 - 26
1
2022 - 05 - 18
1
2022 - 05 - 17
1
2022 - 04 - 25
1
2022 - 04 - 07
1
2022 - 03 - 23
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 28
2
2022 - 02 - 01
1
2021 - 12 - 16
1
2021 - 11 - 12
1
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
24
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
49
19:00
43
20:00
35
20:20
3
21:00
26
22:00
44
23:00
40
Source
www.biospace.com
5
www.globenewswire.com
4
www.prnewswire.com
34
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvsef
crawled time :
11:00
save search
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
-1.62%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$5.0
-1.48%
-1.5%
2.3M
|
Health Technology
|
-34.37%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-1.67%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.73
-0.81%
-0.81%
5.8K
|
Health Technology
|
37.82%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published:
2024-03-27
(Crawled : 11:00)
- biospace.com/
CRBU
|
$3.98
-0.25%
-0.25%
930K
|
Health Technology
|
-21.15%
|
O:
1.58%
H:
0.58%
C:
-0.39%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-0.52%
|
O:
0.24%
H:
0.42%
C:
0.4%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.62%
|
O:
0.49%
H:
0.84%
C:
-0.07%
TGTX
|
$14.25
1.06%
1.05%
3.2M
|
Health Technology
|
-8.68%
|
O:
0.71%
H:
0.39%
C:
0.13%
DTIL
|
$10.33
6.72%
6.29%
31K
|
Health Technology
|
-24.08%
|
O:
0.39%
H:
4.22%
C:
1.41%
precision
business
year
update
financial
results
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.935
3.16%
3.06%
5M
|
Manufacturing
|
-10.17%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.12%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.81%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.09%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
Opthea Strengthens Team with Key Clinical and Regulatory Hires
Published:
2024-02-01
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.41%
|
O:
1.55%
H:
0.79%
C:
0.25%
ALC
|
$80.76
0.19%
0.0%
940K
|
Health Technology
|
7.32%
|
O:
0.24%
H:
1.54%
C:
1.46%
OPT
|
News
|
$3.38
2.37%
2K
|
Health Technology
|
24.72%
|
O:
-0.74%
H:
6.84%
C:
2.6%
key
Tyrosine Kinase Inhibitors Market to Grow at a CAGR of 8.42% between 2023 to 2028; Industry Trends, Driving Forces, Challenges & Market Forecast | Technavio
Published:
2024-01-25
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
5.16%
|
O:
-1.23%
H:
1.34%
C:
1.34%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-12.74%
|
O:
-3.67%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-11.88%
|
O:
-0.44%
H:
0.19%
C:
-0.08%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
0.45%
|
O:
-1.92%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.3%
|
O:
-0.14%
H:
0.77%
C:
0.77%
market
Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published:
2024-01-12
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.25%
|
O:
2.07%
H:
0.0%
C:
-0.06%
ERAS
|
$1.93
4.32%
4.15%
440K
|
|
-5.13%
|
O:
0.0%
H:
4.62%
C:
-1.03%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-11.92%
|
O:
-0.16%
H:
0.43%
C:
0.02%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
1.37%
|
O:
0.25%
H:
0.36%
C:
0.1%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-10.29%
|
O:
0.71%
H:
0.56%
C:
0.42%
melanoma
research
global
market
ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development
Published:
2023-10-03
(Crawled : 11:00)
- globenewswire.com
SLRN
|
$4.6
-4.56%
-4.78%
2M
|
|
-50.67%
|
O:
-0.2%
H:
0.0%
C:
-3.59%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.67%
|
O:
-1.6%
H:
0.36%
C:
-0.46%
growth
Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published:
2023-08-16
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
20.4%
|
O:
5.46%
H:
0.0%
C:
-2.87%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
10.07%
|
O:
-0.67%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
0.81%
|
O:
-0.99%
H:
1.45%
C:
1.36%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.62%
|
O:
-0.2%
H:
0.34%
C:
-0.26%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
15.12%
|
O:
-0.77%
H:
0.79%
C:
0.17%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-4.6%
|
O:
-0.4%
H:
0.73%
C:
-0.24%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
10.72%
|
O:
0.56%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
1.11%
|
O:
-1.36%
H:
0.88%
C:
0.07%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.05%
|
O:
-1.33%
H:
0.0%
C:
0.0%
disease
market
Coherus to Acquire Surface Oncology
Published:
2023-06-16
(Crawled : 11:00)
- globenewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
13.0%
|
O:
0.75%
H:
0.14%
C:
0.14%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.53%
|
O:
1.03%
H:
0.29%
C:
-0.59%
SURF
|
$1.07
-0.93%
-1.41%
0
|
Health Technology
|
44.59%
|
O:
31.08%
H:
2.06%
C:
-18.38%
CHRS
|
$2.19
0.46%
0.46%
810K
|
Health Technology
|
-59.55%
|
O:
-12.06%
H:
0.42%
C:
-12.87%
acquire
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
Published:
2023-04-17
(Crawled : 11:00)
- biospace.com/
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
16.46%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.18%
|
O:
0.47%
H:
0.01%
C:
-0.38%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
95.16%
|
O:
0.07%
H:
0.24%
C:
-0.71%
financial
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published:
2023-04-07
(Crawled : 11:00)
- prnewswire.com
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
market
Clostridium Diagnostics Market to grow at a CAGR of 13.69% from 2022 to 2027, Driven by the growing prevalence of CDI - Technavio
Published:
2023-03-27
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.49%
|
O:
0.55%
H:
1.46%
C:
-0.08%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-1.77%
|
O:
0.99%
H:
0.78%
C:
-0.37%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
13.37%
|
O:
6.51%
H:
1.75%
C:
1.4%
TRIB
|
$1.81
-3.87%
2.8K
|
Health Technology
|
93.58%
|
O:
1.6%
H:
0.0%
C:
-6.32%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.27%
|
O:
1.46%
H:
0.53%
C:
-0.25%
growing
diagnostics
market
Dermatitis Global Market Research Report 2023: An $8.57 Billion Market by 2027 - Long-term Forecasts to 2032
Published:
2023-03-20
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
20.62%
|
O:
1.07%
H:
0.0%
C:
-0.06%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.49%
|
O:
0.98%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-31.34%
|
O:
-0.5%
H:
1.38%
C:
1.23%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
15.31%
|
O:
0.78%
H:
0.74%
C:
0.72%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
19.14%
|
O:
1.38%
H:
1.16%
C:
1.13%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
8.86%
|
O:
0.19%
H:
1.18%
C:
1.04%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.87%
|
O:
0.4%
H:
0.0%
C:
0.0%
report
dermatitis
research
global
market
Cervical Cancer Drugs Global Market Research Report 2023 Featuring F. Hoffmann-La Roche, Hetero, GSK, Eli Lilly, Pfizer, Alnylam, Allergan, Biocon, Bristol-Myers Squibb, and Novartis
Published:
2023-02-24
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
2.96%
|
O:
-1.25%
H:
0.59%
C:
0.59%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
9.51%
|
O:
-0.25%
H:
0.03%
C:
-0.81%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
123.29%
|
O:
-0.46%
H:
0.38%
C:
-1.34%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-31.18%
|
O:
-0.41%
H:
0.15%
C:
-1.31%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.05%
|
O:
-0.98%
H:
0.16%
C:
-0.55%
research
global
report
novartis
cancer
market
Insights on the Pharmaceutical API Manufacturing Global Market to 2032: North America was the Largest Region in 2022
Published:
2023-02-22
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
14.04%
|
O:
0.48%
H:
0.0%
C:
-2.77%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.38%
|
O:
0.53%
H:
1.82%
C:
1.82%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-1.27%
|
O:
-0.48%
H:
0.14%
C:
0.14%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
9.23%
|
O:
0.98%
H:
0.03%
C:
-1.06%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
12.75%
|
O:
0.19%
H:
0.0%
C:
-0.91%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
123.3%
|
O:
0.37%
H:
1.18%
C:
0.11%
ALB
|
News
|
$114.21
1.71%
0.0%
1.7M
|
Process Industries
|
-53.59%
|
O:
0.43%
H:
1.9%
C:
1.42%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
10.45%
|
O:
-0.66%
H:
0.76%
C:
-0.22%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.05%
|
O:
0.54%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.78%
|
O:
0.04%
H:
0.04%
C:
-1.11%
america
global
market
Attention deficit hyperactivity disorder (ADHD) drugs market size to increase by USD 9.61 billion from 2020 to 2025; North America to account for 40% of market growth - Technavio
Published:
2023-02-20
(Crawled : 11:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
america
growth
market
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2306, a Proposed Biosimilar of Cosentyx® (Secukinumab)
Published:
2022-11-01
(Crawled : 11:00)
- biospace.com/
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
45.74%
|
O:
1.13%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
16.81%
|
O:
0.47%
H:
0.09%
C:
-0.55%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-14.51%
|
O:
-0.36%
H:
0.0%
C:
0.0%
bat2306
cosentyx
solutions
biosimilar
trial
Non-melanoma Skin Cancer Market size to grow by USD 180.97 Mn with 36% of the growth to originate from North America - Technavio
Published:
2022-10-19
(Crawled : 11:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
50.95%
|
O:
-1.98%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
22.3%
|
O:
-0.52%
H:
0.06%
C:
-0.75%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
29.89%
|
O:
0.96%
H:
0.22%
C:
-0.76%
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
24.45%
|
O:
0.0%
H:
0.0%
C:
-6.48%
ICAD
|
$1.58
3.95%
3.8%
100K
|
Technology Services
|
-22.84%
|
O:
-0.51%
H:
6.63%
C:
1.53%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
7.85%
|
O:
-0.32%
H:
0.41%
C:
-1.24%
america
skin
cancer
growth
market
Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published:
2022-10-19
(Crawled : 11:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
50.95%
|
O:
-1.98%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
5.11%
|
O:
-1.18%
H:
0.56%
C:
-1.11%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
17.39%
|
O:
-0.38%
H:
0.04%
C:
-1.58%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
22.3%
|
O:
-0.52%
H:
0.06%
C:
-0.75%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-9.64%
|
O:
0.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
29.89%
|
O:
0.96%
H:
0.22%
C:
-0.76%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
14.09%
|
O:
-1.37%
H:
0.0%
C:
0.0%
therapeutics
diabetes
market
← Previous
1
2
3
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.